Clinical Trial: Development of a Quantitative Systems Pharmacology-Based Host-Pathogen-Drug Interaction Model and Exploration of Novel Meropenem Therapeutic Strategies for Sepsis (China)

Posted On: 2026-08-31

China, Aug. 31 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Development of a Quantitative Systems Pharmacology-Based Host-Pathogen-Drug Interaction Model and Exploration of Novel Meropenem Therapeutic Strategies for Sepsis'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131004

Registration Time: 2026/08/27

Type: Observational study

Primary Sponsor: Tongji Hospital of Tongji University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=339924

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Development of a Quantitative Systems Pharmacology-Based Host-Pathogen-Drug Interaction Model and Exploration of Novel Meropenem Therapeutic Strategies for Sepsis (China)